194 related articles for article (PubMed ID: 22354369)
41. Combined plaque radiotherapy and transpupillary thermotherapy in choroidal melanoma: 5 years' experience.
Bartlema YM; Oosterhuis JA; Journée-De Korver JG; Tjho-Heslinga RE; Keunen JE
Br J Ophthalmol; 2003 Nov; 87(11):1370-3. PubMed ID: 14609837
[TBL] [Abstract][Full Text] [Related]
42. PARAFOVEAL CAPILLARY DENSITY AFTER PLAQUE RADIOTHERAPY FOR CHOROIDAL MELANOMA: Analysis of Eyes Without Radiation Maculopathy.
Say EA; Samara WA; Khoo CT; Magrath GN; Sharma P; Ferenczy S; Shields CL
Retina; 2016 Sep; 36(9):1670-8. PubMed ID: 27232466
[TBL] [Abstract][Full Text] [Related]
43. Palladium-103 radiation therapy for small choroidal melanoma.
Semenova E; Finger PT
Ophthalmology; 2013 Nov; 120(11):2353-7. PubMed ID: 23774104
[TBL] [Abstract][Full Text] [Related]
44. Ruthenium-106 versus iodine-125 plaque brachytherapy of 571 choroidal melanomas with a thickness of ≥5.5 mm.
Filì M; Trocme E; Bergman L; See TRO; André H; Bartuma K; Girnita L; All-Eriksson C; Seregard S; Stålhammar G
Br J Ophthalmol; 2020 Jan; 104(1):26-32. PubMed ID: 30910871
[TBL] [Abstract][Full Text] [Related]
45. Comparison of episcleral plaque and proton beam radiation therapy for the treatment of choroidal melanoma.
Wilson MW; Hungerford JL
Ophthalmology; 1999 Aug; 106(8):1579-87. PubMed ID: 10442907
[TBL] [Abstract][Full Text] [Related]
46. The comparison of ruthenium brachytherapy and simultaneous transpupillary thermotherapy of choroidal melanoma with brachytherapy alone.
Yarovoy AA; Magaramov DA; Bulgakova ES
Brachytherapy; 2012; 11(3):224-9. PubMed ID: 22104351
[TBL] [Abstract][Full Text] [Related]
47. Collaborative ocular melanoma study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma. I. Visual acuity after 3 years COMS report no. 16.
Melia BM; Abramson DH; Albert DM; Boldt HC; Earle JD; Hanson WF; Montague P; Moy CS; Schachat AP; Simpson ER; Straatsma BR; Vine AK; Weingeist TA;
Ophthalmology; 2001 Feb; 108(2):348-66. PubMed ID: 11158813
[TBL] [Abstract][Full Text] [Related]
48. Geographic atrophy and choroidal melanoma located 3 mm apart.
Geirsdottir A; Hungerford J; Stefansson E; Jonasson F; Helgadottir G; Sigurdsson H
Acta Ophthalmol; 2008 Aug; 86(5):584-5. PubMed ID: 18221498
[No Abstract] [Full Text] [Related]
49. Efficacy and Safety of Low-Dose Iodine Plaque Brachytherapy for Juxtapapillary Choroidal Melanoma.
Oellers P; Mowery YM; Perez BA; Stinnett S; Mettu P; Vajzovic L; Light K; Steffey BA; Cai J; Dutton JJ; Buckley EG; Halperin EC; Marks LB; Kirsch DG; Mruthyunjaya P
Am J Ophthalmol; 2018 Feb; 186():32-40. PubMed ID: 29199010
[TBL] [Abstract][Full Text] [Related]
50. [Iodine-125-brachytherapy of malignant choroid melanoma. II: Long-term functional outcome].
Kreissig I; Rose D; Simader E
Klin Monbl Augenheilkd; 1996 Jul; 209(1):7-12. PubMed ID: 8965481
[TBL] [Abstract][Full Text] [Related]
51. Management of diffuse choroidal hemangioma in Sturge-Weber syndrome with Ruthenium-106 plaque radiotherapy.
Kubicka-Trząska A; Karska-Basta I; Oleksy P; Romanowska-Dixon B
Graefes Arch Clin Exp Ophthalmol; 2015 Nov; 253(11):2015-9. PubMed ID: 26004077
[TBL] [Abstract][Full Text] [Related]
52. Palladium-103 plaque radiation therapy for American Joint Committee on cancer T3- and T4-staged choroidal melanomas.
Semenova E; Finger PT
JAMA Ophthalmol; 2014 Feb; 132(2):205-13. PubMed ID: 24287555
[TBL] [Abstract][Full Text] [Related]
53. Effect of plaque brachytherapy dose and dose rate on risk for disease-related mortality in 1238 patients with choroidal melanoma.
Filì M; Trocme E; Herrspiegel C; Seregard S; Stålhammar G
Br J Ophthalmol; 2021 Jan; 105(1):57-62. PubMed ID: 32430342
[TBL] [Abstract][Full Text] [Related]
54. The COMS Randomized Trial of Iodine 125 Brachytherapy for Choroidal Melanoma: IV. Local Treatment Failure and Enucleation in the First 5 Years after Brachytherapy. COMS Report No. 19.
Jampol LM; Moy CS; Murray TG; Reynolds SM; Albert DM; Schachat AP; Diddie KR; Engstrom RE; Finger PT; Hovland KR; Joffe L; Olsen KR; Wells CG;
Ophthalmology; 2020 Apr; 127(4S):S148-S157. PubMed ID: 32200815
[TBL] [Abstract][Full Text] [Related]
55. Vision Loss Following Episcleral Brachytherapy for Uveal Melanoma: Development of a Vision Prognostication Tool.
Aziz HA; Singh N; Bena J; Wilkinson A; Singh AD
JAMA Ophthalmol; 2016 Jun; 134(6):615-20. PubMed ID: 27101414
[TBL] [Abstract][Full Text] [Related]
56. BRACHYTHERAPY ALONE OR WITH NEOADJUVANT PHOTODYNAMIC THERAPY FOR AMELANOTIC CHOROIDAL MELANOMA: Functional Outcomes and Local Tumor Control.
Blasi MA; Laguardia M; Tagliaferri L; Scupola A; Villano A; Caputo CG; Pagliara MM
Retina; 2016 Nov; 36(11):2205-2212. PubMed ID: 27124879
[TBL] [Abstract][Full Text] [Related]
57. Plaque radiotherapy for juxtapapillary choroidal melanoma: treatment complications and visual outcomes in 650 consecutive cases.
Sagoo MS; Shields CL; Emrich J; Mashayekhi A; Komarnicky L; Shields JA
JAMA Ophthalmol; 2014 Jun; 132(6):697-702. PubMed ID: 24652552
[TBL] [Abstract][Full Text] [Related]
58. Does escalation of the apical dose change treatment outcome in beta-radiation of posterior choroidal melanomas with 106Ru plaques?
Hermann RM; Pradier O; Lauritzen K; Ott M; Schmidberger H; Hess CF
Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1360-6. PubMed ID: 11955750
[TBL] [Abstract][Full Text] [Related]
59. Choroidal metastasis of cutaneous malignant melanoma treated by ruthenium-106 plaque irradiation.
Anteby I; Axer-Siegel R; Pe'er J
Ann Ophthalmol; 1993 Sep; 25(9):339-41. PubMed ID: 8297070
[TBL] [Abstract][Full Text] [Related]
60. Ruthenium brachytherapy for uveal melanomas: Factors affecting the development of radiation complications.
Pagliara MM; Tagliaferri L; Azario L; Lenkowicz J; Lanza A; Autorino R; Caputo CG; Gambacorta MA; Valentini V; Blasi MA
Brachytherapy; 2018; 17(2):432-438. PubMed ID: 29275868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]